ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,195Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 1107

$1.38M Total Retail Price of All Prescriptions

Rank: 40 out of 1107

954 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 954 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 954 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 19,511 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
OMEPRAZOLE 895 692 1 4
HYDROCODONE-ACETAMINOPHEN 842 672 S3 2 1
LISINOPRIL 743 663 3 2
LEVOTHYROXINE SODIUM 715 642 4 3
METFORMIN HCL 594 490 5 8
FUROSEMIDE 502 403 6 7
METOPROLOL SUCCINATE 495 472 7 16
GABAPENTIN 489 415 8 9
METOPROLOL TARTRATE 468 344 9 10
SIMVASTATIN 404 350 10 5
HYDROCHLOROTHIAZIDE 387 366 11 11
CITALOPRAM HBR 362 291 12 17
PRAVASTATIN SODIUM 346 273 13 12
WARFARIN SODIUM 340 323 14 15
AMLODIPINE BESYLATE 339 292 15 6
TRAMADOL HCL 305 245 16 26
TRAZODONE HCL 305 248 16 33
POTASSIUM CHLORIDE 266 238 18 14
ATORVASTATIN CALCIUM 254 221 19 13
ATENOLOL 248 212 20 19
NEXIUM 241 181 21 18
ZOLPIDEM TARTRATE 234 181 22 22
SERTRALINE HCL 220 188 23 20
CRESTOR 209 161 24 23
PANTOPRAZOLE SODIUM 204 171 25 30
NAMENDA 198 177 26 42
SPIRONOLACTONE 190 175 27 72
MIRTAZAPINE 190 136 27 61
ALLOPURINOL 180 147 29 36
LOSARTAN POTASSIUM 177 172 30 29
GLIPIZIDE 177 97 30 64
PREDNISONE 170 147 32 40
TRIAMTERENE-HCTZ 170 143 32 62
BUSPIRONE HCL 162 143 34 107
DIGOXIN 160 144 35 52
FLUOXETINE HCL 157 90 36 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 154 135 37 24
SYNTHROID 152 139 38 70
TAMSULOSIN HCL 151 118 39 30
ISOSORBIDE MONONITRATE ER 151 126 39 34
CARVEDILOL 145 130 41 27
AZITHROMYCIN 139 113 42 35
MELOXICAM 138 114 43 25
SPIRIVA 135 120 44 57
CLOPIDOGREL 134 120 45 28
DONEPEZIL HCL 134 132 45 32
POLYETHYLENE GLYCOL 3350 131 101 47 46
COLESTIPOL HCL 131 74 47 259
VENLAFAXINE HCL ER 127 100 49 117
PLAVIX 123 109 50 39
BUMETANIDE 118 106 51 123
VENLAFAXINE HCL 117 96 52 193
KLOR-CON 10 114 109 53 143
CYMBALTA 113 65 54 50
METOCLOPRAMIDE HCL 113 94 54 116
CYCLOBENZAPRINE HCL 113 57 R 54 56
PROPRANOLOL HCL 109 85 57 134
DICLOFENAC SODIUM 105 93 58 74
ALPRAZOLAM 100 88 59 87
ALENDRONATE SODIUM 99 99 60 41
RAMIPRIL 98 66 61 84
ESCITALOPRAM OXALATE 96 68 62 82
CLONIDINE HCL 96 71 62 53
AMITRIPTYLINE HCL 94 61 R 64 48
CIPROFLOXACIN HCL 94 91 64 59
METHYLPREDNISOLONE 91 77 66 119
KLOR-CON M20 91 84 66 75
CELEBREX 84 77 68 85
RANITIDINE HCL 81 49 69 21
MORPHINE SULFATE ER 80 29 S2 70 156
DIVALPROEX SODIUM 79 62 71 96
LANTUS 78 43 72 49
ACETAMINOPHEN-CODEINE 77 77 S3 73 120
BENAZEPRIL HCL 77 57 73 86
FINASTERIDE 77 77 73 130
DILTIAZEM 24HR CD 76 68 76 126
SOTALOL 74 73 77 222
LANSOPRAZOLE 73 61 78 102
LOSARTAN-HYDROCHLOROTHIAZIDE 73 51 78 66
DIOVAN 72 68 80 51
PROAIR HFA 72 44 80 37
DOXEPIN HCL 72 48 80 180
GLIMEPIRIDE 72 60 80 43
PROMETHAZINE HCL 71 35 R 84 44
LOVASTATIN 70 69 85 55
FLUTICASONE PROPIONATE 70 61 85 38
WELCHOL 68 50 87 240
TRIAMTERENE-HYDROCHLOROTHIAZID 66 66 88 185
DETROL LA 65 44 89 223
CILOSTAZOL 64 50 90 194
OLANZAPINE 62 14 91 176
BYSTOLIC 61 56 92 138
PROPAFENONE HCL 60 54 93 431
GEMFIBROZIL 60 42 93 107
AMOXICILLIN 59 41 95 90
ADVAIR DISKUS 59 29 95 54
DIOVAN HCT 58 41 97 106
LUNESTA 58 57 97 329
NITROFURANTOIN MONO-MACRO 57 55 99 207
GLYBURIDE 57 53 R 99 68
AMLODIPINE BESYLATE-BENAZEPRIL 56 36 101 77
ROPINIROLE HCL 55 33 102 69
FENTANYL 55 39 S2 102 105
OXYBUTYNIN CHLORIDE 54 32 104 171
EVISTA 54 54 104 135
DOXAZOSIN MESYLATE 53 30 106 92
HYDROXYZINE HCL 53 39 R 106 162
TORSEMIDE 53 51 106 177
KLOR-CON M10 52 52 109 159
FAMOTIDINE 52 52 109 111
TIZANIDINE HCL 52 22 109 73
CARBIDOPA-LEVODOPA 52 23 109 122
RISPERIDONE 51 46 113 79
METHOTREXATE 50 50 114 287
OXYCODONE-ACETAMINOPHEN 50 44 S2 114 104
LEVETIRACETAM 50 24 114 141
NYSTATIN 50 37 114 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.